Skip to main content

Table 2 Univariate linear regression analysis of factors correlated with the serum CRP concentration

From: Effect of erythropoietin-stimulating agent on uremic inflammation

Variable Regression coefficient p value
Age 0.136 <0.0001
Sex (F: 1, M: 2) 0.004 0.897
Diabetic nephropathy (no: 1, yes: 2) −0.008 0.8087
BMI 0.052 0.1341
SBP −0.087 0.0113
DBP −0.068 0.0484
Duration of nephrologist care −0.06 0.0775
CTR 0.134 0.0003
Albumin −0.246 <0.0001
LDL-C −0.084 0.0341
HDL-C −0.153 <0.0001
Hemoglobin −0.11 0.001
BUN 0.011 0.743
Creatinine −0.102 0.0023
eGFR 0.122 0.0002
Uric acid 0.045 0.1861
Calcium −0.118 0.0004
Phosphate −0.021 0.5353
Intact-PTH −0.007 0.8627
Platelets 0.061 0.068
WBC 0.14 <0.0001
ESA −0.119 0.0005
ESA dose −0.124 0.0007
ARB −0.071 0.0361
ACE-I −0.052 0.1282
ARB or ACE-I −0.075 0.0261
ARB and ACE-I −0.059 0.0841
CCB −0.1 0.0032
other anti-HT −0.065 0.0562
AST-120 −0.036 0.2943
Vitamin D −0.058 0.0863
Iron agents −0.072 0.1059
  1. BMI; body mass index, SBP; systolic blood pressure, DBP; diastolic blood pressure, CTR; Cardiothoracic ratio, WBC; white blood cell, Plt; platelets, LDL-C; low density lipoprotein cholesterol, HDL-C; high density lipoprotein cholesterol, BUN; blood urea nitrogen, eGFR; estimated glomerular filtration rate, PTH; parathyroid hormone, CRP; C-reactive protein, ESA; erythropoietin-stimulating agents, ARB; angiotensin-II receptor blockers, ACE-I; angiotensin-converting enzyme inhibitors, CCB; calcium channel blockers, anti-HT; antihypertensive.